NCT06343987

Brief Summary

The goal of this clinical trial is to test a physical activity program in patients with metastatic breast cancer and overweight receiving endocrine-based treatment. The aim of the study is to assess the feasibility of a 12-week physical activity program in this patient group in terms of adherence, recruitment rate, retention and acceptability. Potential effects on metabolic health, body composition, physical performance, obesity-related biomarkers and patient-related outcomes are explored. The hypothesis is that improving metabolic health and health-related quality of life through physical activity can optimize cancer care. Participants will randomized 2:1 to either a physical activity program or care as usual.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 19, 2024

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

March 6, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 3, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2025

Completed
Last Updated

April 27, 2025

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

March 6, 2024

Last Update Submit

April 24, 2025

Conditions

Keywords

Metastatic Breast CancerPhysical ActivityAdiposityEndocrine TherapyObesity

Outcome Measures

Primary Outcomes (5)

  • Recruitment rate

    Recruitment rate calculated by the amount of included partcipants of those eligible

    1 year

  • Adherence to the training program

    Adherence to the training program assessed by the mean attendance rate

    1 year

  • Retention

    Retention rate to the study assessed by the proportion of participants in each study arm that completes the study period

    1,5 years

  • Adherence to other study procedures

    Adherence to other study procedures assessed by the proportion of completed questionnaires and blood samples at the specified time-points

    1,5 years

  • Acceptability

    Acceptability of the study intervention assessed by the proportion of participants in the intervention arm that anwers "yes" to the question: "Would you recommend others to participate in the physical activity program?"

    1 year

Other Outcomes (17)

  • Health-related quality of life as assessed by EORTC-QLQ-30

    Until the end of study

  • Metabolic score

    Until the end of study

  • Self-efficacy of cancer coping as assessed by CBI-12

    Until end of study

  • +14 more other outcomes

Study Arms (2)

Intervention Arm

EXPERIMENTAL

14 participants

Behavioral: Physical Activity

Observational Arm

NO INTERVENTION

7 participants

Interventions

12-week physical activity program with training 3 times a week. The training consists of high-intensity training such as weight-lifting and cardiovascular training, and low-intensity training such as relaxation and stretching.

Intervention Arm

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed metastatic breast cancer
  • BMI ≥ 25
  • Receive first-line endocrine-based therapy
  • Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1

You may not qualify if:

  • Psychological, familial, sociological, or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; these conditions will be discussed with the patient before registration in the trial.
  • Physical health condition that either is unsafe for participation or prevents the patient from participating adequately in the physical activity program.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Oncology, Aarhus University Hospital

Aarhus N, Central Jutland, 8200, Denmark

Location

Related Publications (1)

  • Wissing M, Skovlund P, Drysdale S, Amidi A, Zachariae R, Laurberg T, Borgquist S. Feasibility of an exercise program in endocrine-treated metastatic breast cancer patients with overweight: protocol for the FEMA study. Pilot Feasibility Stud. 2025 Apr 2;11(1):36. doi: 10.1186/s40814-025-01621-9.

MeSH Terms

Conditions

Breast NeoplasmsObesityMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Signe SB Borgquist, MD, PhD

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Continuous inclusion. Randomized 2:1 - intervention group and observational group, respectively.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair Professor, Senior Consultant, PhD

Study Record Dates

First Submitted

March 6, 2024

First Posted

April 3, 2024

Study Start

February 19, 2024

Primary Completion

April 24, 2025

Study Completion

April 24, 2025

Last Updated

April 27, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations